Decay acceleration of the complement alternative pathway C3 convertase

Immunopharmacology - Tập 42 - Trang 167-173 - 1999
Dennis E Hourcade1, Lynne M Mitchell1, M.Edward Medof2
1Department of Medicine, Division of Rheumatology, Washington University School of Medicine, 660 S. Euclid, Box 8045, St. Louis, MO 63110, USA
2Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA

Tài liệu tham khảo

Brodbeck, 1996, Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor, J. Immunol., 156, 2528, 10.4049/jimmunol.156.7.2528 Caras, 1987, Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins, Nature, 325, 545, 10.1038/325545a0 Carroll, 1998, The role of complement and complement receptors in induction and regulation of immunity, Annu. Rev. Immunol., 16, 545, 10.1146/annurev.immunol.16.1.545 Davis, A.E., III, 1998. C1 inhibitor gene and hereditary angioedema. In: Volanakis, J.E., Frank, M.M. (Eds.), The Human Complement System in Health and Disease. Marcel Dekker, New York, pp. 455–480. Fearon, 1996, The instructive role of innate immunity in the acquired immune response, Science, 272, 50, 10.1126/science.272.5258.50 Fehlhammer, 1977, Crystal structure of bovine trypsinogen at 1–8 A resolution: II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin, J. Mol. Biol., 111, 415, 10.1016/S0022-2836(77)80062-4 Fishelson, 1982, C3 convertase of human complement: enhanced formation and stability of the enzyme generated with nickel instead of magnesium, J. Immunol., 129, 2603, 10.4049/jimmunol.129.6.2603 Freer, 1970, Chymotrypsinogen: 2.5-A crystal structure, comparison with a-chymotrypsin, and implications for zynogen activation, Biochemistry, 9, 1997, 10.1021/bi00811a022 Horiuchi, 1991, Site-directed mutagenesis of the region around cys-241 of complement component C2, J. Immunol., 147, 584, 10.4049/jimmunol.147.2.584 Hourcade, 1989, The regulators of complement activation (RCA) gene cluster, Adv. Immunol., 45, 381, 10.1016/S0065-2776(08)60697-5 Hourcade, 1995, Analysis of the short consensus repeats of human complement factor B by site-directed mutagenesis, J. Biol. Chem., 270, 19716, 10.1074/jbc.270.34.19716 Hourcade, 1998, A conserved element in the serine protease domain of complement factor B, J. Biol. Chem., 273, 25996, 10.1074/jbc.273.40.25996 Kristensen, 1991, The superfamily of C3b/C4b-binding proteins, Federation Proceedings, 46, 2463 Kuhn, 1996, Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H, Eur. J. Immunol., 26, 2383, 10.1002/eji.1830261017 Kuttner-Kondo, 1996, Molecular modeling and mechanism of action of human decay-accelerating factor, Protein Eng., 9, 1143, 10.1093/protein/9.12.1143 Lambris, 1984, Isolation and characterization of a 33,000-Dalton fragment of complement factor B with catalytic and C3b binding activity, J. Biol. Chem., 259, 12685, 10.1016/S0021-9258(18)90800-8 Liszewski, M.K., Atkinson, J.P., 1998. Regulatory proteins of complement. In: Volanakis, J.E., Frank, M.M. (Eds.), The Human Complement System in Health Disease. Marcel Dekker, New York, pp. 149–165. Medof, 1986, Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid, Biochemistry, 25, 6740, 10.1021/bi00370a003 Medof, 1987, Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement, Proc. Natl. Acad. Sci. U.S.A., 84, 2007, 10.1073/pnas.84.7.2007 Müller-Eberhard, H.J., 1992. Inflammation: Basic Principles and Clinical Correlates. In: Gallin, J., Goldstein, I., Snyderman, R. (Eds.), Complement: Chemistry and Pathways. Raven Press, New York, pp. 33–62. Polley, 1967, Enhancement of the hemolytic activity of the second component of human complement by oxidation, J. Exp. Med., 126, 1013, 10.1084/jem.126.6.1013 Pryzdial, 1987, Alternative complement pathway activation fragment Ba binds to C3b, J. Biol. Chem., 262, 1519, 10.1016/S0021-9258(19)75665-8 Smith, 1984, MHC class III products: an electron microscope study of the C3 convertase of human complement, J. Exp. Med., 159, 324, 10.1084/jem.159.1.324 Tuckwell, 1997, Surface loops adjacent to the cation-binding site of the complement factor B von Willebrand factor type A module determine C3b binding specificity, Biochemistry, 36, 6605, 10.1021/bi963155l Ueda, 1987, Probing functional sites on complement protein B with monoclonal antibodies, J. Immunol., 138, 1143, 10.4049/jimmunol.138.4.1143 Vogel, 1982, The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate, J. Biol. Chem., 257, 8292, 10.1016/S0021-9258(18)34330-8 Volanakis, J.E., 1998. Overview of the complement system. In: Volanakis, J.E., Frank, M.M. (Eds.), The Human Complement System in Health and Disease. Marcel Dekker, New York, pp. 9–32. Volanakis, J.E., Arlaud, G.J., 1998. Complement enzymes. In: Volanakis, J.E., Frank, M.M. (Eds.), The Human Complement System in Health and Disease. Marcel Dekker, New York, pp. 49–81.